EPISODE · Jan 29, 2026 · 1 MIN
Long-Term Outcomes of Faricimab in Diabetic Macular Edema
from TheBrief.Health · host TheBrief.Health
Four-year data show faricimab delivers sustained vision and retinal improvements in diabetic macular edema, reducing injection frequency and easing treatment burden for patients with diabetes.
What this episode covers
Four-year data show faricimab delivers sustained vision and retinal improvements in diabetic macular edema, reducing injection frequency and easing treatment burden for patients with diabetes.
NOW PLAYING
Long-Term Outcomes of Faricimab in Diabetic Macular Edema
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m